Literature DB >> 1459378

Diagnosis, antibiotic treatment and outcome of acute tonsillitis: report of a WHO Regional Office for Europe study in 17 European countries.

F W Touw-Otten1, K S Johansen.   

Abstract

The diagnostic and prescribing habits of general practitioners from 17 European countries for 4094 patients with acute tonsillitis were assessed, and differences in outcome were identified. At least 10 general practitioners from each country filled in a questionnaire for each episode of acute tonsillitis treated during a three month period, November 1989-May 1990. Differences in days of fever and illness were tested by one-way analysis of variance. Bacteriological tests were rarely used for diagnosis in East Germany, Poland and the Netherlands, while a high percentage (70-96%) occurred in Turkey, Romania, Israel, Yugoslavia, Finland and Greece. Group A beta-haemolytic streptococci (40 per cent) and a negative test result (43 per cent) were the most common results. Ninety per cent or more patients were treated with an antibiotic. Oral penicillin was especially prescribed in the northern countries of Europe and parenteral penicillin in southern Europe. For almost all countries the mean number of days with fever was between 2 or 3 days. The mean number of days with illness differed greatly (F = 62.12; P = 0.0000). Turkey had the lowest mean (2.56), while Poland had the highest mean (8.23).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1459378     DOI: 10.1093/fampra/9.3.255

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  16 in total

1.  Do patients with sore throat benefit from penicillin? A randomized double-blind placebo-controlled clinical trial with penicillin V in general practice.

Authors:  C F Dagnelie; Y van der Graaf; R A De Melker
Journal:  Br J Gen Pract       Date:  1996-10       Impact factor: 5.386

Review 2.  Reconsidering sore throats. Part 2: Alternative approach and practical office tool.

Authors:  W J McIsaac; V Goel; P M Slaughter; G W Parsons; K V Woolnough; P T Weir; J R Ennet
Journal:  Can Fam Physician       Date:  1997-03       Impact factor: 3.275

Review 3.  Reconsidering sore throats. Part I: Problems with current clinical practice.

Authors:  W J McIsaac; V Goel; P M Slaughter; G W Parsons; K V Woolnough; P T Weir; J R Ennet
Journal:  Can Fam Physician       Date:  1997-03       Impact factor: 3.275

4.  Impact on antibiotic prescription of rapid antigen detection testing in acute pharyngitis in adults: a randomised clinical trial.

Authors:  Carl Llor; Jordi Madurell; Montse Balagué-Corbella; Mónica Gómez; Josep Maria Cots
Journal:  Br J Gen Pract       Date:  2011-05       Impact factor: 5.386

5.  A randomized controlled trial of antibiotics on symptom resolution in patients presenting to their general practitioner with a sore throat.

Authors:  R W Howe; M R Millar; J Coast; M Whitfield; T J Peters; S Brookes
Journal:  Br J Gen Pract       Date:  1997-05       Impact factor: 5.386

6.  Urinary tract infections. Management mayhem?

Authors:  T Dixon
Journal:  Can Fam Physician       Date:  1993-03       Impact factor: 3.275

7.  Diagnosing streptococcal sore throat in adults: randomized controlled trial of in-office aids.

Authors:  Graham Worrall; James Hutchinson; Gregory Sherman; Joseph Griffiths
Journal:  Can Fam Physician       Date:  2007-04       Impact factor: 3.275

8.  Treatment of streptococcal pharyngitis with amoxycillin once a day.

Authors:  P Shvartzman; H Tabenkin; A Rosentzwaig; F Dolginov
Journal:  BMJ       Date:  1993-05-01

9.  Patient involvement in assessing consultation quality: a quantitative study of the Patient Enablement Instrument in Poland.

Authors:  Teresa R B Pawlikowska; Jeremy J Walker; Pawel R Nowak; Wieslawa Szumilo-Grzesik
Journal:  Health Expect       Date:  2009-08-28       Impact factor: 3.377

Review 10.  Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective.

Authors:  Stephan Harbarth; Werner Albrich; Christian Brun-Buisson
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.